ContraFect (CFRX) Tops Q3 EPS by 1c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/29/2026

1. NOW
2. MSFT
3. GOOGL
4. FTNT
5. EBAY
6. CMG
7. TENB
8. BIIB
9. KLAC
10. ETSY

Go back to ContraFect (CFRX) Tops Q3 EPS by 1c

ContraFect Corporation Announces Third Quarter 2015 Financial and Operating Results

November 12, 2015 6:00 PM EST

YONKERS, NY -- (Marketwired) -- 11/12/15 -- ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW)

FDA Fast Track Designation Granted to CF-301, currently in Phase 1 clinical trials for Staph bacteremia, including MRSA Key Management Additions: Dr. Cara Cassino, Chief Medical Officer; Joshua Muntner, Head of Business Development; and Paul Boni, Head of Investor Development and Strategy $9.6 Million Raised Through the Exercise of Class B... More